TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Tuesday, November 20, 2007

Big Win for Pfizer in Celebrex Litigation

Pharmalot has the details and the order (in Word form, with metadata indicating it originated from plaintiffs' firm Lieff Cabraser) finding no Daubert-worthy evidence of causation at the most common dose of 200 mg.  You can also get the order in PDF form here: Download CelebrexDaubert.pdf.

See also the Reuters story.


(I have done some work in the Cox-2 litigation, but none in the Celebrex case and none of any sort for Pfizer.)

Experts & Science, MDLs and Class Actions, Products Liability | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Big Win for Pfizer in Celebrex Litigation:


Post a comment